INTERVIEW: Gert Bos On How The Unexpected Can Pack A Punch In Medtech Regulations
This article was originally published in Clinica
Executive Summary
Gert Bos, champion of notified bodies and president of TEAM-NB, knows the medtech regulatory sphere like the back of his hand. He holds interesting and strong views on notified bodies and their evolving role with the ongoing developments in EU medtech regulations. Amanda Maxwell caught up with him, following the announcement of his departure from the notified body BSI to work as an industry consultant
You may also be interested in...
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.
First Danish Notified Body Named Under EU's Medical Device Regulation
The EU now has a total of 45 notified bodies under the MDR.